These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 25879652)

  • 1. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
    Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
    BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
    Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
    Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.
    Huang WT; Weng SW; Wei YC; You HL; Wang JT; Eng HL
    Int J Clin Exp Pathol; 2014; 7(10):6841-51. PubMed ID: 25400767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.
    Jansen R; Moehlendick B; Bartenhagen C; Tóth C; Lehwald N; Stoecklein NH; Knoefel WT; Lachenmayer A
    Sci Rep; 2018 Jul; 8(1):10637. PubMed ID: 30006612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations.
    Kim YH; Hong EK; Kong SY; Han SS; Kim SH; Rhee JK; Hwang SK; Park SJ; Kim TM
    Oncotarget; 2016 Apr; 7(17):23825-36. PubMed ID: 27009864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
    Sia D; Hoshida Y; Villanueva A; Roayaie S; Ferrer J; Tabak B; Peix J; Sole M; Tovar V; Alsinet C; Cornella H; Klotzle B; Fan JB; Cotsoglou C; Thung SN; Fuster J; Waxman S; Garcia-Valdecasas JC; Bruix J; Schwartz ME; Beroukhim R; Mazzaferro V; Llovet JM
    Gastroenterology; 2013 Apr; 144(4):829-40. PubMed ID: 23295441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance.
    Vincent-Chong VK; Salahshourifar I; Woo KM; Anwar A; Razali R; Gudimella R; Rahman ZA; Ismail SM; Kallarakkal TG; Ramanathan A; Wan Mustafa WM; Abraham MT; Tay KK; Zain RB
    PLoS One; 2017; 12(4):e0174865. PubMed ID: 28384287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization.
    Uhm KO; Park YN; Lee JY; Yoon DS; Park SH
    Cancer Genet Cytogenet; 2005 Feb; 157(1):37-41. PubMed ID: 15676145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degenerate oligonucleotide primed PCR-comparative genomic hybridization.
    Lee JY; Park YN; Uhm KO; Park SY; Park SH
    J Korean Med Sci; 2004 Oct; 19(5):682-7. PubMed ID: 15483344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelotype analysis of intrahepatic cholangiocarcinoma.
    Kang YK; Kim YI; Kim WH
    Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
    Halldórsdóttir AM; Sander B; Göransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
    Genes Chromosomes Cancer; 2011 Feb; 50(2):113-21. PubMed ID: 21117067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic landscape of pancreatic neuroendocrine tumors.
    Gebauer N; Schmidt-Werthern C; Bernard V; Feller AC; Keck T; Begum N; Rades D; Lehnert H; Brabant G; Thorns C
    World J Gastroenterol; 2014 Dec; 20(46):17498-506. PubMed ID: 25516664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
    Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
    Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of transcriptional regulatory network and copy number variation in intrahepatic cholangiocarcinoma.
    Li L; Lian B; Li C; Li W; Li J; Zhang Y; He X; Li Y; Xie L
    PLoS One; 2014; 9(6):e98653. PubMed ID: 24897108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis.
    Rijken AM; Hu J; Perlman EJ; Morsberger LA; Long P; Kern SE; Hruban RH; Yeo CJ; Griffin CA
    Genes Chromosomes Cancer; 1999 Nov; 26(3):185-91. PubMed ID: 10502315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
    Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma.
    You HL; Weng SW; Li SH; Wei YC; Sheu JJ; Chen CM; Huang WT
    Exp Mol Pathol; 2012 Jun; 92(3):281-6. PubMed ID: 22366251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum and precision oncology for biliary tract carcinoma.
    Lin J; Cao Y; Yang X; Li G; Shi Y; Wang D; Long J; Song Y; Mao J; Xie F; Bai Y; Zhang L; Yang X; Wan X; Wang A; Guan M; Zhao L; Hu K; Pan J; Huo L; Lu X; Mao Y; Sang X; Zhang H; Wang K; Wang X; Zhao H
    Theranostics; 2021; 11(10):4585-4598. PubMed ID: 33754015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.